Lv2
150 积分 2025-09-06 加入
How China became the new world leader in clinical trials
21天前
已完结
Comparative Review of Clinical Trial Regulations in Different Countries: Current Scenario and Future Prospect
25天前
已完结
Multicentre trials: a US regulatory perspective
26天前
已完结
Multicentre european trials: their design, execution and relevance
26天前
已完结
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
1个月前
已完结
Physical Accessibility of Medicines in Countries Hosting Trials for FDA Approval
2个月前
已关闭
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials
2个月前
已完结
Advancing Global Pharmacoequity in Oncology
2个月前
已关闭
A Call for Innovative Translational and Clinical Research to Address China’s Unique Cancer Landscape
3个月前
已完结
Clinical Benefit, Trials, and Regulatory Approval of Oncology Indications Under Multiple Expedited Programs for Drug Marketing in China, 2018-2024
3个月前
已关闭
皖公网安备34019202002308
